799-0131124-2/11/1

Novartis Pharmaceuticals Corporation — FEI 2210396

Refusal Details

Date
March 28, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
58MCY25 SECUKINUMAB
Charges
75